Bionomics Limited - Latest News [Page 1]
Bionomics’ Validates 3rd BNC105 Cancer Application
Monday, 4 June 2007, 3:52 pm | Bionomics Limited
Australian drug discovery company, Bionomics Limited (ASX: BNO), announced today that their latest findings indicate that BNC105 disrupts the vasculature in human prostate tumours grown in mice, expanding on its previously demonstrated preclinical ... More >>
